Approval · Notice of Compliance 12759 · 2011
FLUANXOL: Notice of Compliance 12759
Issued November 3, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12759
- Date
- November 3, 2011
- Company
- Lundbeck Canada IncSt-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in Formulation; Updates to the Product Monograph and labels
- Therapeutic class
- Antipsychotic Agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLUANXOL | Not yet assigned | — |
Medicinal ingredients
- FLUPENTIXOL DIHYDROCHLORIDE 0.5 MG per TAB
- FLUPENTIXOL DIHYDROCHLORIDE 3 MG per TAB
- FLUPENTIXOL DIHYDROCHLORIDE 5 MG per TAB